Name | SARS-CoV-2-IN-15 |
---|
Description | SARS-CoV-2-IN-15 (compound 11) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.49 μM. SARS-CoV-2-IN-15 is a niclosamide analogue. SARS-CoV-2-IN-15 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C14H9ClF3NO2 |
---|---|
Molecular Weight | 315.67 |